Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Not Confirmed
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Not Confirmed
Not Confirmed
23-25 September, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
BioProcess Internation...BioProcess International
Industry Trade Show
Not Confirmed
22-26 September, 2024
SPE Annual TechnicalSPE Annual Technical
Industry Trade Show
Not Confirmed
23-25 September, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-re-unlocking-life-changing-potential-in-complex-molecules-without-sacrificing-time-to-market
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/bms-bayer-takeda-pfizer-downsize-to-combat-cost-pressures-meet-restructuring-plans
10 Sep 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/bridgebio-stop-development-therapy-genetic-disorder-2024-09-10/
06 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/06/2942094/0/en/BridgeBio-Pharma-Reports-Inducement-Grants-under-Nasdaq-Listing-Rule-5635-c-4.html
30 Aug 2024
// REUTERS
https://www.reuters.com/business/healthcare-pharmaceuticals/alnylam-shares-slide-after-heart-drug-data-fails-impress-investors-2024-08-30/
30 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/30/2938591/0/en/BridgeBio-Shares-Data-on-Serum-TTR-Increase-When-Switching-Participants-from-Placebo-and-Tafamidis-to-Acoramidis-in-ATTRibute-CM-and-its-Open-Label-Extension.html
29 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/29/2937687/0/en/BridgeBio-to-Present-Additional-Analyses-from-the-Phase-3-ATTRibute-CM-Trial-of-Acoramidis-in-Patients-with-Transthyretin-Amyloid-Cardiomyopathy-ATTR-CM-at-the-ESC-Congress-2024-an.html
28 Aug 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/08/28/2936905/0/en/BridgeBio-Pharma-to-Participate-in-September-Investor-Events.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?